Compounded Tirzepatide vs. Mounjaro
Mounjaro is a brand-name, FDA-approved tirzepatide product. Compounded tirzepatide is prepared by a licensed pharmacy for an individual patient and is not FDA-approved. Here’s how they compare.
| Compounded Tirzepatide | Mounjaro (brand) | |
|---|---|---|
| FDA approval | Not FDA-approved (compounded) | FDA-approved |
| Active molecule | Tirzepatide | Tirzepatide |
| Prepared by | State-licensed compounding pharmacy, per prescription | Manufacturer (Eli Lilly) |
| Typical cash price | $229 first / $349 mo (Orik) | $1,000–$1,400+/mo |
| Requires prescription | Yes | Yes |
Compounded medications are not FDA-approved and are not reviewed by the FDA the way approved drugs are. They are a legal option when prescribed by a licensed provider and prepared by a licensed pharmacy.
Source: FDA — Compounding and the FDA: Questions and Answers
Frequently asked questions
Is compounded tirzepatide the same as Mounjaro?+
They contain the same active molecule (tirzepatide), but they are not the same product. Mounjaro is FDA-approved and made by the manufacturer; compounded tirzepatide is prepared by a licensed pharmacy for an individual patient and is not FDA-approved.
Is compounded tirzepatide cheaper than Mounjaro?+
Typically yes. Orik’s compounded tirzepatide starts at $229 for the first month versus $1,000+ cash for brand-name Mounjaro, though pricing and availability vary.
Are compounded medications FDA-approved?+
No. They are prepared by state-licensed pharmacies for individual patients pursuant to a valid prescription, but they are not individually FDA-approved.
Not sure which is right for you?
A licensed provider reviews your health profile and recommends an appropriate option. No insurance required.
Start your free evaluationNo insurance required · Provider-reviewed · Cancel anytime